Peakdale Molecular Reinforces its Commitment to Science and Extends its Discovery Park Lease
News Mar 02, 2016
Peakdale Molecular has extended its Discovery Park lease for a further ten years. The company, which is part of the Concept Life Sciences group, has been a tenant in Sandwich, Kent for six years and the lease renewal further signifies its commitment to the local area. Peakdale operates laboratory facilities at Discovery Park with the capacity for up to 50 chemists.
Commenting on the extension Paul Barber, Managing Director of Discovery Park said: “Peakdale Molecular has been present at Discovery Park since its launch in 2012, it was one of just five companies at the start and there are now over 125 companies. I am delighted that they have remained committed to Discovery Park and the facilities it offers.”
Peakdale’s Chief Operating Officer, Dr Paul Doyle added: “Discovery Park is one of Europe’s leading science and technology parks and home to a host of international companies. The Park is a vibrant hub of activity and offers the opportunity to share, engage and connect with other science based organisations; something we find incredibly valuable.
“Since the acquisition by Concept Life Sciences we have undergone a period of change which is set to transform into accelerated growth throughout 2016 and onwards. Securing a further 10-year tenancy at Discovery Park is testament to this growth period and indicates our ongoing commitment to our passionate and dedicated workforce.” In addition to the Sandwich site the company’s headquarters are located in the Peak District. Around 70 scientific staff are located here, with the capacity for 100 in total.
Michael Fort, Chairman of Concept Life Sciences, said: “The Discovery Park in Sandwich is a world renowned centre for science and technology and provides the perfect location for Peakdale which has over two decades of experience of supporting the pharmaceutical and biotech industries. Whilst Peakdale has its own positive reputation we have also found that being housed at Discovery Park also greatly assists with recruitment and we have been able to attract some of the brightest and best scientists to our team.”
Compound Offers Pain-relief of Opioids Without Addictive PropertiesNews
Researchers have engineered a new compound that animal tests suggest could offer the pain-relieving properties of opioids such as morphine and oxycodone without the risk of addiction.READ MORE
PhoreMost and Plexxikon Collaborate to Identify Novel Drug TargetsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.READ MORE
Anti-Malaria Drugs Delivered With CaffeineNews
Many drug delivery systems, such as capsules and tablets, can be difficult to swallow, especially for children. Making delivery systems out of polymer gels is an attractive option, but usually requires hazardous levels of heavy metals to be used. Now, scientists have found a way to build these gels from caffeine molecules.READ MORE
Comments | 0 ADD COMMENT
15th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry
Sep 09 - Sep 12, 2018
CE in the Biotechnology & Pharmaceutical Industries: 20th Symposium on the Practical Applications for the Analysis of Proteins, Nucleotides & Small Molecules
Sep 09 - Sep 12, 2018